
Meb Pharma Consultancy (OPC) Private Limited
About Meb Pharma Consultancy (OPC) Private Limited
Data last updated:
Meb Pharma Consultancy (OPC) Private Limited is a one person company based in Nagpur, Maharashtra, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 06 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24290MH2019OPC330254.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Mangesh Eknath Bhad.
Its latest financial statements are for the year ended 31 March 2025. The registered office is at Nirmal Nagari Building No F.No.7 – A Umred Road Nagpur, Maharashtra, India – 440009.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.68 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹35,400 (net margin 1.9%) and EBITDA of ₹47,300 (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years and 30% over five years.
Company details
Contact details
Meb Pharma Consultancy (OPC) Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressNirmal Nagari Building No F.No.7 – A Umred Road Nagpur, Maharashtra, India – 440009
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Meb Pharma Consultancy (OPC) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Meb Pharma Consultancy is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Meb Pharma Consultancy (OPC) Private Limited, buy the company report.
Financials of Meb Pharma Consultancy (OPC) Private Limited
FY 2025 filings availableMeb Pharma Consultancy (OPC) Private Limited reported revenue of ₹18.68 Lakh (up 179% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 179% growth in the latest year. EBITDA rose 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47,300 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35,400 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meb Pharma Consultancy (OPC) Private Limited, buy the company report.
Board of directors of Meb Pharma Consultancy (OPC) Private Limited
Meb Pharma Consultancy has 1 current director and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mangesh Eknath Bhad Also directs: Meb Pharma Private Limited | Director | 06 Sep 2019 | 7 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Meb Pharma Consultancy (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meb Pharma Consultancy (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Meb Pharma Consultancy (OPC) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Meb Pharma Consultancy (OPC) Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Eknath Pandurang Bhad was appointed as Nominee on 06 Sep 2019.
Frequently asked questions
Meb Pharma Consultancy is an active company based in Nagpur, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 06 September 2019 (7+ years old) and is registered under CIN U24290MH2019OPC330254.
Meb Pharma Consultancy has 1 current director:
- Mangesh Eknath Bhad - Director
The latest financial statements of Meb Pharma Consultancy on record with the MCA are for the year ended 31 March 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Meb Pharma Consultancy is U24290MH2019OPC330254. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meb Pharma Consultancy was incorporated on 06 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Nagpur.
Eknath Pandurang Bhad was appointed as Nominee on 06 Sep 2019. Mangesh Eknath Bhad was appointed as Director on 06 Sep 2019.
The registered office of Meb Pharma Consultancy is at Nirmal Nagari Building No F.No.7 – A Umred Road Nagpur, Maharashtra, India – 440009.
Meb Pharma Consultancy operates in the business outsourcing industry, in the business and IT consulting segment.
Meb Pharma Consultancy can be reached at its registered office: Nirmal Nagari Building No F.No.7 – A Umred Road Nagpur, Maharashtra, India – 440009.
Meb Pharma Consultancy is registered under the jurisdiction of the Registrar of Companies (ROC), Nagpur.

